2026-04-17T05:39:28Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1244862025-12-05T12:33:11Zcom_2072_1057col_2072_478916col_2072_478917

00925njm 22002777a 4500 dc Casanovas Taltavull, Teresa author Peña Cala, Maria Carmen author 2018-09-12T12:28:05Z 2018-09-12T12:28:05Z 2017-02-01 2018-07-24T12:11:16Z Key Clinical Message: Our case report discusses the usefulness of administering romiplostim as a second-line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid-induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy. Síndrome de Cushing Administració de medicaments Cushing's syndrome Administration of drugs Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids